Joseph Shulman Rhythm Pharmaceuticals, Inc. (RYTM) insider trading activity

Joseph Shulman is Chief Technical Officer of RHYTHM PHARMACEUTICALS, INC.. Currently has a direct ownership of 8,509 shares of RYTM, which is worth approximately $845,879. The most recent transaction as insider was on Oct 30, 2025, when has been sold 9,748 shares (Common Stock) at a price of $115.24 per share, resulting in proceeds of $1,123,359. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.51K

0% 3M change

Infinity% 12M change

Total Value Held $845,879

Joseph Shulman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 30 2025	SELL Open market or private sale	$1,123,359 $115.24 p/Share	9,748 Reduced 53.39%	8,509 Common Stock
Oct 30 2025	BUY Exercise of conversion of derivative security	$298,873 $30.66 p/Share	9,748 Added 34.81%	18,257 Common Stock
Oct 28 2025	SELL Open market or private sale	$323,753 $115.01 p/Share	2,815 Reduced 24.86%	8,509 Common Stock
Oct 28 2025	BUY Exercise of conversion of derivative security	$81,663 $29.01 p/Share	2,815 Added 19.91%	11,324 Common Stock
Oct 16 2025	SELL Open market or private sale	$1,616,077 $111.94 p/Share	14,437 Reduced 62.92%	8,509 Common Stock
Oct 16 2025	BUY Exercise of conversion of derivative security	$418,817 $29.01 p/Share	14,437 Added 38.62%	22,946 Common Stock
Sep 02 2025	SELL Open market or private sale	$1,767,039 $105.3 p/Share	16,781 Reduced 66.35%	8,509 Common Stock

Sep 02 2025	BUY Exercise of conversion of derivative security	$486,816 $29.01 p/Share	16,781 Added 39.89%	25,290 Common Stock
Aug 21 2025	SELL Open market or private sale	$419,093 $100.07 p/Share	4,188 Reduced 32.98%	8,509 Common Stock
Aug 21 2025	BUY Exercise of conversion of derivative security	$114,541 $27.35 p/Share	4,188 Added 24.8%	12,697 Common Stock
Aug 11 2025	SELL Open market or private sale	$358,878 $90.08 p/Share	3,984 Reduced 31.89%	8,509 Common Stock
Aug 11 2025	BUY Exercise of conversion of derivative security	$27,091 $6.8 p/Share	3,984 Added 24.18%	12,493 Common Stock
Jul 09 2025	SELL Open market or private sale	$619,828 $77.78 p/Share	7,969 Reduced 48.36%	8,509 Common Stock
Jul 09 2025	BUY Exercise of conversion of derivative security	$54,189 $6.8 p/Share	7,969 Added 32.6%	16,478 Common Stock
Feb 19 2025	SELL Open market or private sale	$70,266 $57.22 p/Share	1,228 Reduced 12.61%	8,509 Common Stock
Feb 16 2025	BUY Exercise of conversion of derivative security	-	4,125 Added 29.76%	9,737 Common Stock
Feb 12 2025	SELL Open market or private sale	$26,611 $56.74 p/Share	469 Reduced 7.71%	5,612 Common Stock
Feb 11 2025	SELL Open market or private sale	$45,678 $57.53 p/Share	794 Reduced 99.25%	6 Common Stock
Feb 11 2025	BUY Exercise of conversion of derivative security	-	1,562 Added 18.51%	6,875 Common Stock
Feb 09 2025	BUY Exercise of conversion of derivative security	-	2,656 Added 33.33%	5,313 Common Stock
Feb 04 2025	SELL Open market or private sale	$76,129 $59.43 p/Share	1,281 Reduced 32.53%	2,657 Common Stock
Feb 01 2025	BUY Exercise of conversion of derivative security	-	3,938 Added 50.0%	3,938 Common Stock
Nov 11 2024	SELL Open market or private sale	$888,100 $66.87 p/Share	13,281 Reduced 100.0%	0 Common Stock
Nov 11 2024	BUY Exercise of conversion of derivative security	$187,129 $14.09 p/Share	13,281 Added 50.0%	13,281 Common Stock
Jul 16 2024	SELL Open market or private sale	$554,804 $53.0 p/Share	10,468 Reduced 99.71%	30 Common Stock

Joseph Shulman

Chief Technical Officer

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RYTM shares.

Notify only if

Value

Insider Trading

Get notified when an Rhythm Pharmaceuticals, Inc. insider buys or sells RYTM shares.

Notify only if

Operation

Value

Type

News

Receive news related to RHYTHM PHARMACEUTICALS, INC.

Track Activities on RYTM

Account